Jump Financial
FTH icon

Jump Financial’s Faeth Therapeutics FTH Stock Holding History

Jump Financial’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$694K Buy
+23,345
New +$727K 0.01% 1539
2022
Q1 		– Sell
-590
Closed -$68K – 1883
2021
Q4 		$68K Buy
+590
New +$88.2K ﹤0.01% 1273

Other funds holding FTH

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return

Jump Financial's FTH Position: Q3 2026 in Review

Jump Financial opened a new position in Faeth Therapeutics (FTH) in Q3 2026: 23,345 shares worth $694K. The stake represents 0.01% of the portfolio and ranks #1539 among its holdings. This is a return to the name: Jump Financial previously reported a position in FTH as recently as Q4 2021.

Jump Financial first reported a position in FTH in Q4 2021 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold FTH as of Q3 2026.

  • Jump Financial held 23,345 shares of Faeth Therapeutics worth $694K as of Q3 2026.
  • Faeth Therapeutics was a new Jump Financial position in Q3 2026.
  • Faeth Therapeutics made up 0.01% of Jump Financial's portfolio in Q3 2026, its #1539 holding.
  • Jump Financial first reported a position in Faeth Therapeutics in Q4 2021 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.